We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KC:NASDAQKingsoft Cloud Holdings Limited Analysis

Data as of 2026-05-19 - not real-time

$14.87

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Kingsoft Cloud (KC) is trading at $14.87, well below its 52‑week high of $18.52 and beneath the 20‑day SMA of $16.04, indicating short‑term weakness despite a bullish overall trend. The company posted a robust 23.7% revenue growth YoY and Q4 2025 revenue surged 24% on AI demand, yet margins remain thin (gross margin 15.7%) and profitability is negative (operating margin –2.4%, EPS –$0.51). Financial health is strained with a debt‑to‑equity ratio above 100%, negative free cash flow and a beta of 2.1, driving an 82% 30‑day volatility and a high overall risk profile. Nevertheless, analysts’ target prices average $20.5–$21 and the DCF model suggests a fair value far above the current price, yielding a 41% upside potential, while market sentiment is in “Extreme Greed” territory. Recent material news includes the filing of the FY2025 20‑F and ESG report, underscoring compliance and ESG focus, but no operational catalysts beyond AI‑driven demand have been announced. In this mixed backdrop, the stock appears undervalued on price metrics but carries significant execution and regulatory risks.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Price below 20‑day and 50‑day SMAs
  • Bearish MACD histogram
  • High short‑term volatility and beta

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong revenue growth and AI demand
  • Continued negative cash flow and high debt
  • Support level around $14.66 offering downside cushion

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued price relative to target and DCF fair value
  • Long‑term expansion of China cloud and AI markets
  • Potential for balance‑sheet improvement and cash‑flow turnaround

Key Metrics & Analysis

Financial Health

Revenue Growth23.70%
Profit Margin-9.80%
P/E Ratio-108.2
ROE-12.74%
ROA-2.18%
Debt/Equity113.29
P/B Ratio3.3
Op. Cash Flow$3.8B
Free Cash Flow$-3892685568
Industry P/E38.2

Technical Analysis

TrendBullish
RSI45.2
Support$14.66
Resistance$18.52
MA 20$16.04
MA 50$15.19
MA 200$13.65
MACDBearish
VolumeIncreasing
Fear & Greed Index89.61

Valuation

Fair Value$285.14
Target Price$21.06
Upside/Downside41.65%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta2.11
Volatility82.53%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.